# OnCo record gemcitabine-cisplatin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/gemcitabine-cisplatin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "gemcitabine-cisplatin" ;
  schema:name "Gemcitabine + cisplatin"@en ;
  schema:description "Gemcitabine plus cisplatin has been the chemotherapy backbone for bile duct cancer since 2010 and is now given with immunotherapy."@en ;
  schema:url <https://onco.cc/drugs/gemcitabine-cisplatin/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Gemcitabine> ;
  owl:sameAs <http://www.wikidata.org/entity/Q414143> ;
  schema:citation <https://en.wikipedia.org/wiki/Gemcitabine> ;
  onco:status "standard-of-care" ;
  onco:modality "Cytotoxic regimen" ;
  onco:cancers <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/cup-unfavourable/>, <https://onco.cc/cancers/locoregionally-advanced-nasopharyngeal-carcinoma/>, <https://onco.cc/cancers/recurrent-metastatic-nasopharyngeal-carcinoma/>, <https://onco.cc/cancers/gallbladder/>, <https://onco.cc/cancers/biliary-tract-cancer/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/> ;
  onco:trials <https://onco.cc/trials/abc-02/>, <https://onco.cc/trials/topaz-1/>, <https://onco.cc/trials/keynote-966/>, <https://onco.cc/trials/nct05771480/>, <https://onco.cc/trials/nct06109779/>, <https://onco.cc/trials/nct02453282/>, <https://onco.cc/trials/nct02542293/>, <https://onco.cc/trials/nct03003962/>, <https://onco.cc/trials/nct06225596/>, <https://onco.cc/trials/nct07221253/>, <https://onco.cc/trials/nct06591520/>, <https://onco.cc/trials/acticca-1/>, <https://onco.cc/trials/swog-s1815/>, <https://onco.cc/trials/opt-in/>, <https://onco.cc/trials/polcagb/>, <https://onco.cc/trials/gain-igbc/>, <https://onco.cc/trials/rugb/>, <https://onco.cc/trials/debate/>, <https://onco.cc/trials/eortc-1607-pembro-cisgem/>, <https://onco.cc/trials/abc-07/>, <https://onco.cc/trials/abc-12/>, <https://onco.cc/trials/ea2197-ivonescimab/>, <https://onco.cc/trials/trap-btc/>, <https://onco.cc/trials/gap-phase2-mdacc/>, <https://onco.cc/trials/nife/> .